Ginkgo Bioworks is looking to cut expenses and personnel in an effort to return to profitability and break even by the end of 2026.
The company said it is planning to reduce operating expenses — including a 25% reduction in labor spending across both research and development, and general and administrative departments, according to a Thursday afternoon press release.
During an investor call on Thursday, Ginkgo CEO Jason Kelly said that the company is working on exact numbers for the layoffs. According to SEC filings, Ginkgo had 1,218 employees at the end of last year.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.